Literature DB >> 26401717

IFN-γ-Dependent Recruitment of CD4(+) T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection.

Matheus Batista Heitor Carneiro1, Mateus Eustáquio de Moura Lopes1, Leonardo Gomes Vaz1, Louisa Maria Andrade Sousa1, Liliane Martins dos Santos1, Carolina Carvalho de Souza2, Ana Carolina de Angelis Campos1, Dawidson Assis Gomes1, Ricardo Gonçalves2, Wagner Luiz Tafuri2, Leda Quercia Vieira1.   

Abstract

Interferon gamma (IFN-γ) is a key factor in the protection of hosts against intracellular parasites. This cytokine induces parasite killing through nitric oxide and reactive oxygen species production by phagocytes. Surprisingly, during Leishmania amazonensis infection, IFN-γ plays controversial roles. During in vitro infections, IFN-γ induces the proliferation of the amastigote forms of L. amazonensis. However, this cytokine is not essential at the beginning of an in vivo infection. It is not clear why IFN-γ does not mediate protection during the early stages of infection. Thus, the aim of our study was to investigate the role of IFN-γ during L. amazonensis infection. We infected IFN-γ(-/-) mice in the footpad and followed the development of leishmaniasis in these mice compared with that in WT mice. CD4(+) T lymphocytes and macrophages migrated earlier to the site of infection in the WT mice, and the earlier migration of these 2 cell types was associated with lesion development and parasite growth, respectively. These differences in the infiltrate populations were explained by the increased expression of chemokines in the lesions of the WT mice. Thus, we propose that IFN-γ plays a dual role during L. amazonensis infection; it is an important inducer of effector mechanisms, particularly through inducible nitric oxide synthase expression, and conversely, it is a mediator of inflammation and pathogenesis through the induction of the expression of chemokines. Our data provided evidence for a pathogenic effect of IFN-γ production during leishmaniasis that was previously unknown.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26401717      PMCID: PMC4683564          DOI: 10.1089/jir.2015.0043

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  57 in total

1.  Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania.

Authors:  Djalma S Lima-Junior; Diego L Costa; Vanessa Carregaro; Larissa D Cunha; Alexandre L N Silva; Tiago W P Mineo; Fredy R S Gutierrez; Maria Bellio; Karina R Bortoluci; Richard A Flavell; Marcelo T Bozza; João S Silva; Dario S Zamboni
Journal:  Nat Med       Date:  2013-06-09       Impact factor: 53.440

2.  The role of IL-10 in promoting disease progression in leishmaniasis.

Authors:  M M Kane; D M Mosser
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

3.  Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL/6 mice.

Authors:  Denise Fonseca Côrtes; Matheus Batista Heitor Carneiro; Liliane Martins Santos; Talita Correia de Oliveira Souza; Tatiane Uceli Maioli; Ana Luiza C Duz; Maria Letícia Ramos-Jorge; Luis Carlos Crocco Afonso; Claudia Carneiro; Leda Quercia Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-09       Impact factor: 2.743

4.  Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.

Authors:  Douglas E Jones; Mark R Ackermann; Ulrike Wille; Christopher A Hunter; Phillip Scott
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae meningitis.

Authors:  Andrew J Mitchell; Belinda Yau; James A McQuillan; Helen J Ball; Lay Khoon Too; Arby Abtin; Paul Hertzog; Stephen L Leib; Cheryl A Jones; Sebastien K Gerega; Wolfgang Weninger; Nicholas H Hunt
Journal:  J Immunol       Date:  2012-10-15       Impact factor: 5.422

6.  Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice.

Authors:  L M A Sousa; M B H Carneiro; M E Resende; L S Martins; L M Dos Santos; L G Vaz; P S Mello; D M Mosser; M A P Oliveira; L Q Vieira
Journal:  Parasite Immunol       Date:  2014-01       Impact factor: 2.280

7.  Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.

Authors:  Matheus Batista Heitor Carneiro; Louisa Maria de Andrade e Sousa; Leonardo Gomes Vaz; Liliane Martins Dos Santos; Luciano Vilela; Carolina Carvalho de Souza; Ricardo Gonçalves; Wagner Luis Tafuri; Luís Carlos Crocco Afonso; Denise Fonseca Côrtes; Leda Quercia Vieira
Journal:  Parasitol Int       Date:  2014-08-04       Impact factor: 2.230

8.  CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria.

Authors:  Carla Claser; Benoît Malleret; Sin Yee Gun; Alicia Yoke Wei Wong; Zi Wei Chang; Pearline Teo; Peter Chi Ee See; Shanshan Wu Howland; Florent Ginhoux; Laurent Rénia
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

9.  IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.

Authors:  Caio T Fagundes; Vivian V Costa; Daniel Cisalpino; Flávio A Amaral; Patrícia R S Souza; Rafael S Souza; Bernhard Ryffel; Leda Q Vieira; Tarcília A Silva; Alena Atrasheuskaya; George Ignatyev; Lirlândia P Sousa; Danielle G Souza; Mauro M Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

10.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more
  10 in total

1.  Gut Microbiota-Derived Indole-3-Carboxylate Influences Mucosal Integrity and Immunity Through the Activation of the Aryl Hydrocarbon Receptors and Nutrient Transporters in Broiler Chickens Challenged With Eimeria maxima.

Authors:  Inkyung Park; Hyoyoun Nam; Doyun Goo; Samiru S Wickramasuriya; Noah Zimmerman; Alexandra H Smith; Thomas G Rehberger; Hyun S Lillehoj
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

2.  Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection.

Authors:  Eric Henrique Roma; Juan Pereira Macedo; Grazielle Ribeiro Goes; Juliana Lauar Gonçalves; Waldionê de Castro; Daniel Cisalpino; Leda Quercia Vieira
Journal:  Parasit Vectors       Date:  2016-04-07       Impact factor: 3.876

3.  IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.

Authors:  Elizabeth K Naglak; Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2016-09-06       Impact factor: 3.441

4.  A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.

Authors:  Marcus Vinícius Alves-Silva; Dirlei Nico; Alexandre Morrot; Marcos Palatnik; Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2017-02-23       Impact factor: 7.561

Review 5.  The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-Leishmania amazonensis Interactions Lead to a Progressive Chronic Disease.

Authors:  Matheus B Carneiro; Nathan C Peters
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561

6.  Resistance Against Leishmania major Infection Depends on Microbiota-Guided Macrophage Activation.

Authors:  Mateus Eustáquio Lopes; Liliane Martins Dos Santos; David Sacks; Leda Quercia Vieira; Matheus B Carneiro
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

7.  The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.

Authors:  Eduardo S Yamamoto; Bruno L S Campos; Jéssica A Jesus; Márcia D Laurenti; Susan P Ribeiro; Esper G Kallás; Mariana Rafael-Fernandes; Gabriela Santos-Gomes; Marcelo S Silva; Deborah P Sessa; João H G Lago; Débora Levy; Luiz F D Passero
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

8.  PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.

Authors:  Daniel Holanda Barroso; Sarah De Athayde Couto Falcão; Jorgeth de Oliveira Carneiro da Motta; Laís Sevilha Dos Santos; Gustavo Henrique Soares Takano; Ciro Martins Gomes; Cecília Beatriz Fiuza Favali; Beatriz Dolabela de Lima; Raimunda Nonata Ribeiro Sampaio
Journal:  Front Immunol       Date:  2018-05-11       Impact factor: 7.561

9.  Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.

Authors:  Alessandra M da Fonseca-Martins; Tadeu D Ramos; Juliana E S Pratti; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Lynn Soong; Elvira M Saraiva; Herbert L de Matos Guedes
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

10.  Mapping Alterations Induced by Long-Term Axenic Cultivation of Leishmania amazonensis Promastigotes With a Multiplatform Metabolomic Fingerprint Approach.

Authors:  Frederico Crepaldi; Juliano Simões de Toledo; Anderson Oliveira do Carmo; Leopoldo Ferreira Marques Machado; Daniela Diniz Viana de Brito; Angela Vieira Serufo; Ana Paula Martins Almeida; Leandro Gonzaga de Oliveira; Tiago Queiroga Nery Ricotta; Douglas de Souza Moreira; Silvane Maria Fonseca Murta; Ariane Barros Diniz; Gustavo Batista Menezes; Ángeles López-Gonzálvez; Coral Barbas; Ana Paula Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2019-12-04       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.